BioSpace News Archive

Policy

Bracker & Marcus LLC: Beaumont Hospital to Pay $84.5 Million False Claims Act Settlement

The settlement resolves a qui tam lawsuit filed by whistleblower David Felten, M.D., Ph.D alleging physician kickbacks for referrals.

August 2, 2018
·
2 min read
Genetown

Decibel Therapeutics Research on The Role of Molecular Diversity in Neurons Critical for Hearing Published in Cell

Decibel Therapeutics researchers and Johns Hopkins University professors Ulrich Mueller, Ph.D. (a Decibel co-founder) and Dwight Bergles, Ph.D., published the results of groundbreaking research which may hold the key to discovering new mechanisms behind hearing disorders and tinnitus. C

August 2, 2018
·
3 min read
Drug Development

Apogenix Strengthens Patent Position for Lead Drug Candidate Asunercept

Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that it was granted two key patents for lead immuno-oncology candidate asunercept in multiple territories.

August 2, 2018
·
3 min read
Biotech Beach

Edwards Lifesciences To Present at 38th Annual Canaccord Genuity Growth Conference

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to present at the 38th Annual Canaccord Genuity Growth Conference at the InterContinental Hotel in Boston, MA on Wednesday, August 8, 2018.

August 2, 2018
·
1 min read
Policy

Parata Renews Authorization to Operate by the Defense Health Agency

Parata Systems, the leading pharmacy technology provider, renewed its Defense Health Agency (DHA) level Authority to Operate (ATO), allowing Parata to continue supporting customers in the armed forces and furthering the company’s ability to work within the Department of Defense (DoD) and DHA.

August 2, 2018
·
2 min read
Business

Insulet Reports Second Quarter 2018 Revenue of $124.3 Million, Up 13% Year-Over-Year, and Gross Margin of 66%, Up 710 Basis Points

Full Year 2018 Expected Revenue Growth Revised to 18% to 21%

August 2, 2018
·
11 min read
Deals

Tandem Diabetes Care Announces on August 2, 2018 Proposed Underwritten Public Offering of Common Stock

Tandem Diabetes Care®, Inc. announced that it has commenced a proposed underwritten public offering of its common stock.

August 2, 2018
·
4 min read
Business

Cerus Corporation Reports Second Quarter 2018 Results

Product revenue increases 62% compared to 2017

August 2, 2018
·
13 min read
Business

IAVI and the Public Health Agency of Canada Enter into License Agreement for Technology to Enable Lassa Fever Vaccine Development

IAVI to Apply Expertise in Viral Vector Vaccines to Lassa Fever Prevention Effort

August 2, 2018
·
6 min read
Business

Glaukos Corporation Announces Second Quarter 2018 Financial Results

Glaukos Corporation announced financial results for the second quarter ended June 30, 2018.

August 2, 2018
·
10 min read